Journal of Cellular and Molecular Pharmacology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Case Report   
  • J Cell Mol Pharmacol 2023, Vol 7(5): 184

Genetic Polymorphism and Personalized Medicine Tailoring Treatment to Individuals

Ahmed Berhanu*
Department of Rural Development and Agricultural Extension, Ethiopia
*Corresponding Author : Ahmed Berhanu, Department of Rural Development and Agricultural Extension, Ethiopia, Email: ahmed.berhanu@gmail.com

Received Date: Oct 01, 2023 / Published Date: Oct 30, 2023

Abstract

This article explores the fascinating intersection of genetic polymorphism and personalized medicine, demonstrating how understanding individual genetic variability can revolutionize healthcare. Genetic polymorphism, encompassing single nucleotide polymorphisms and genetic variations, underlies the concept of personalized medicine. This innovative approach empowers healthcare professionals to predict disease susceptibility, optimize drug selection, tailor medication dosages, and customize treatment plans based on a patient’s unique genetic profile. Pharmacogenomics, a key component of personalized medicine, delves into how genetic polymorphism affects drug responses. While personalized medicine holds great promise, challenges like data privacy and ethical considerations must be addressed. In an era of advancing genomics, personalized medicine offers a tailored and more effective future for healthcare.

Citation: Berhanu A (2023) Genetic Polymorphism and Personalized MedicineTailoring Treatment to Individuals. J Cell Mol Pharmacol 7: 184.

Copyright: © 2023 Berhanu A. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top